What does a moderate number of ovalocytes (elliptocytes) on a peripheral blood smear indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What Does a Moderate Number of Ovalocytes/Elliptocytes on Peripheral Blood Smear Mean?

A moderate number of ovalocytes (elliptocytes) on a peripheral blood smear is a nonspecific finding that most commonly indicates iron deficiency anemia, but requires systematic evaluation to exclude thalassemia, myelofibrosis, hereditary elliptocytosis, or other hemolytic conditions.

Clinical Significance and Diagnostic Approach

The presence of ovalocytes/elliptocytes requires interpretation within the broader context of red blood cell indices and clinical presentation. These elongated red blood cells are not pathognomonic for any single condition but serve as an important morphologic clue 1.

Primary Differential Diagnosis

Iron Deficiency Anemia is the most common cause. The correlation between elliptocyte percentage and anemia severity is well-established—as elliptocytes increase, hemoglobin concentration, hematocrit, and mean corpuscular hemoglobin decrease significantly 2. Importantly, elliptocytes correlate better with anemia severity than serum ferritin levels, which can be falsely elevated in inflammatory states 2.

Key diagnostic steps for iron deficiency:

  • Check MCV (typically <80 fL in iron deficiency) 1
  • Measure serum ferritin: <30 μg/L without inflammation, or <100 μg/L with inflammation 3
  • Calculate transferrin saturation: <15% suggests absolute iron deficiency 1
  • Assess reticulocyte index: low RI indicates decreased RBC production 1

Thalassemia must be distinguished from iron deficiency, particularly when microcytosis is present. Recent evidence shows that elliptocytes, along with target cells, teardrop cells, and ovalocytes, demonstrate statistically significant differences in thalassemia screening-positive individuals 4. However, RBC morphology alone has limited discriminatory power and requires hemoglobin electrophoresis for definitive diagnosis 4.

Myelofibrosis represents a critical diagnosis not to miss. Elliptocytosis can appear as an early indicator 2-4 years before overt myelofibrosis develops, particularly in patients with polycythemia vera 5. The classic finding is teardrop cells (dacrocytes), but elliptocytes may precede this 6.

Algorithmic Evaluation

Step 1: Assess MCV and reticulocyte count

  • Microcytic (<80 fL): Consider iron deficiency, thalassemia, anemia of chronic disease 1
  • Normocytic (80-100 fL): Consider myelofibrosis, hemolysis, bone marrow disorders 1
  • Macrocytic (>100 fL): Consider B12/folate deficiency, though elliptocytes are less common 1

Step 2: Iron studies and inflammation markers

  • Ferritin, transferrin saturation, TIBC
  • CRP to assess for inflammation 3
  • In inflammation, ferritin up to 100 μg/L may still indicate iron deficiency 3

Step 3: Additional morphology assessment

  • Examine for target cells, teardrop cells, schistocytes 3, 4
  • Teardrop cells strongly suggest myelofibrosis or "spent" polycythemia vera 6
  • Increased hypochromic cells support iron deficiency 3

Step 4: Specialized testing when indicated

  • Hemoglobin electrophoresis if thalassemia suspected 3
  • Bone marrow biopsy if myelofibrosis suspected (especially with teardrop cells, splenomegaly, or unexplained cytopenias) 7
  • Osmotic fragility testing if hereditary elliptocytosis considered (though this is rare and typically presents with family history)

Critical Pitfalls to Avoid

Do not rely on ferritin alone in the presence of inflammation, infection, or malignancy—it can be falsely elevated despite true iron deficiency 1, 3. Use transferrin saturation and consider functional iron deficiency.

Do not dismiss elliptocytes as "nonspecific" without completing the workup. While occasional elliptocytes appear in normal smears, dominance of this morphology indicates specific pathology 6.

Do not overlook myelofibrosis, especially if elliptocytes are accompanied by teardrop cells, unexplained splenomegaly, or a history of myeloproliferative disorders 5, 6.

Recognize that RBC distribution width (RDW) elevation helps identify mixed microcytic/macrocytic conditions where MCV appears falsely normal 3.

Special Populations

In β-thalassemia minor, increased elliptocytes result from iron overload-related oxidative stress causing membrane damage and cytoskeletal protein alterations 8. These patients show significantly increased elliptocyte counts compared to normal individuals 8.

In malaria-endemic regions, increased ovalocytes may represent a protective response, as ovalocytic red cells show reduced parasitemia 9, 10. However, this is relevant primarily in endemic populations, not routine clinical practice.

Bottom Line

Moderate ovalocytes/elliptocytes demand a systematic evaluation starting with CBC indices, iron studies adjusted for inflammation, and careful review of the complete blood smear for additional morphologic clues. The finding most commonly indicates iron deficiency but requires exclusion of thalassemia and myelofibrosis through targeted testing based on MCV, clinical context, and associated morphologic findings 1, 3, 2.

References

Guideline

cancer- and chemotherapy-induced anemia.

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

Research

Increased ovalocytic red cells and their low parasitemia in malaria infected subjects.

Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1989

Research

Hereditary ovalocytosis and reduced susceptibility to malaria in Papua New Guinea.

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.